Updates are available Correction dated 2021-12-24
Click to view Correction: https://doi.org/10.1007/s00415-021-10941-8
-
Authors
Cappellari, Manuel https://orcid.org/0000-0002-3534-3201
Saia, Valentina
Pracucci, Giovanni
Enrico, Fainardi
Consoli, Arturo
Nappini, Sergio
Castellan, Lucio
Bracco, Sandra
Bergui, Mauro
Cosottini, Mirco
Vangosa, Alessandra Briatico
Vinci, Sergio
Ruggiero, Maria
Puglielli, Edoardo
Chiumarulo, Luigi
Cester, Giacomo
Comelli, Chiara
Silvagni, Umberto
Morosetti, Daniele
Caldiera, Valentina
Cavasin, Nicola
Ledda, Valeria
Sanfilippo, Giuseppina
Saletti, Andrea
Filauri, Pietro
Gallesio, Ivan
Nuzzi, Nunzio Paolo
Amistá, Pitero
Zivelonghi, Cecilia
Plebani, Mauro
Pavia, Marco
Romano, Daniele
Biraschi, Francesco
Menozzi, Roberto
Gasparotti, Roberto
Giorgianni, Andrea
Zini, Andrea
Inzitari, Domenico
Toni, Danilo
Mangiafico, Salvatore
,
- License Information
-
More Information
Article History
Received: 25 June 2021
Revised: 7 November 2021
Accepted: 8 November 2021
First Online: 19 November 2021
Change Date: 24 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-021-10941-8
Declarations
:
: Manuel Cappellari received consulting fees from Boehringer-Ingelheim and Pfizer-BMS, and advisory board from Daiichi Sankyo. Mauro Bergui received consulting fees from Penumbra Inc. Stryker Italia. Giacomo Cester declared to have speaker honoraria with Penumbra Inc. Andrea Saletti received consulting fees from Stryker. Nunzio Paolo Nuzzi received consulting fees from Penumbra Inc. Acandis GmbH. Daniele Romano received consulting fees from Penumbra Inc. Andrea Zini received speaker fees from Ceronovus and consulting fees from Boehringer-Ingelheim. Danilo Toni declared to have speaker honoraria and advisory board relationship with Abbott, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, and Pfizer. Salvatore Mangiafico received consulting fees from Cerenovus. The other authors report no disclosures.
: The present study was in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Need for ethical approval or patient consent for participation in the IRETAS varied among participating hospitals.
: Informed consent to use of anonymized and aggregated data for participation in the IRETAS was obtained in all patients of each center.
